Evidence map›Paper›PMID 37108285›Full record

ReviewInternational journal of molecular sciences2023

From Transgenesis to Genome Editing in Crop Improvement: Applications, Marketing, and Legal Issues.

Daniela Marone, Anna Maria Mastrangelo, Grazia Maria Borrelli

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Daniela MaroneCouncil for Agricultural Research and Economics, Research Centre for Cereal and Industrial Crops, 71122 Foggia, Italy.ORCID 0000-0002-2365-6091
Anna Maria MastrangeloCouncil for Agricultural Research and Economics, Research Centre for Cereal and Industrial Crops, 71122 Foggia, Italy.ORCID 0000-0002-3618-0301
Grazia Maria BorrelliCouncil for Agricultural Research and Economics, Research Centre for Cereal and Industrial Crops, 71122 Foggia, Italy.ORCID 0000-0003-1270-3590
Cereal Research Centre · IT

Funding

Italian Ministry of Agriculture, Food Sovereignty and Forestry (MASAF) D.M. n. 15978/7305/2018, 18 May 2018
6 · The paper itself

Abstract

The biotechnological approaches of transgenesis and the more recent eco-friendly new breeding techniques (NBTs), in particular, genome editing, offer useful strategies for genetic improvement of crops, and therefore, recently, they have been receiving increasingly more attention. The number of traits improved through transgenesis and genome editing technologies is growing, ranging from resistance to herbicides and insects to traits capable of coping with human population growth and climate change, such as nutritional quality or resistance to climatic stress and diseases. Research on both technologies has reached an advanced stage of development and, for many biotech crops, phenotypic evaluations in the open field are already underway. In addition, many approvals regarding main crops have been granted. Over time, there has been an increase in the areas cultivated with crops that have been improved through both approaches, but their use in various countries has been limited by legislative restrictions according to the different regulations applied which affect their cultivation, marketing, and use in human and animal nutrition. In the absence of specific legislation, there is an on-going public debate with favorable and unfavorable positions. This review offers an updated and in-depth discussion on these issues.

Indexed as

Gene EditingPlant BreedingAnimalsCrops, AgriculturalGene Transfer TechniquesHumansMarketingPlants, Genetically Modifiedbiotech cropsbiotech regulationbreedinggenome editingtransgenesis

Identifiers

PMID37108285
PMCPMC10138802
OpenAlexW4365146680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.